Clinical Trial Update: Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of Plozasiran in adults with severe hypertriglyceridemia at risk of acute pancreatitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• Plozasiran

Snippet

Sponsor: Arrowhead Pharmaceuticals | Conditions: Severe Hypertriglyceridemia | Phase 3 | Status: RECRUITING